1. Association of peripheral neuropathy with skeletal muscle mass and function in type two diabetes mellitus patients: A cross-sectional study
- Author
-
Subarna, Mohapatra, Madumathy, Ramachandran, Kishore Kumar, Behera, Nibedita, Priyadarsini, Pranati, Nanda, and Sujata, Devi
- Subjects
Male ,Sarcopenia ,Cross-Sectional Studies ,Nutrition and Dietetics ,Endocrinology ,Diabetes Mellitus, Type 2 ,Diabetic Neuropathies ,Endocrinology, Diabetes and Metabolism ,Quality of Life ,Humans ,Muscle, Skeletal - Abstract
Diabetic peripheral neuropathy (DPN) is considered to be a risk factor for development of sarcopenia. Therefore, our study aimed to detect the association between peripheral neuropathy with skeletal muscle mass and function in type two diabetes mellitus (T2DM) patients.A total of 176 participants, ≥45 years were included in the study. Out of 176, 60 were healthy volunteers, 60 had T2DM without neuropathy, 56 had T2DM with neuropathy. In all the participants peripheral nerve function was assessed by nerve conduction studies (Common peroneal and Sural nerve) and sarcopenia parameters were evaluated according to the Asian Working Group for Sarcopenia (AWGS) criteria.The present study suggested that diabetic peripheral neuropathy (DPN) was associated with decline in muscle mass, which was found only in men. Our study showed a positive correlation between appendicular skeletal muscle index (ASMI) and common peroneal nerve amplitude and sural nerve amplitude with r=0.527, p0.05; r=0.847, p0.001 respectively. Furthermore, in multiple linear regression analyses, we found a positive relationship between ASMI and sural nerve amplitude after adjustment for confounders like age, duration of diabetes, and HbA1C (B=0.739; p0.001).As DPN patients are more prone to developing sarcopenia, and periodic assessment of skeletal muscle mass and function is warranted to initiate early lifestyle interventions in these patients, which will improve their quality of life.
- Published
- 2022
- Full Text
- View/download PDF